Caelus Pharmaceuticals B.V.
Ongoing bankruptcy- KvK
- 60107383
- Court
- Amsterdam
- Bankruptcy number
- F.13/25/78
- Judgment
- March 4, 2025
- Insolvency practitioner
- mr. J.F.H.M. Bartels, Labré Advocaten
Summary
On March 4, 2025, the Rechtbank Amsterdam declared Caelus Pharmaceuticals B.V. bankrupt (insolvency number F.13/25/78). It is a BV from Zegveld (Utrecht). Its KvK number is 60107383. According to the Commercial Register, its main activity is medische laboratoria, trombosediensten en overig behandelingsondersteunend onderzoek. mr. J.F.H.M. Bartels (Labré Advocaten) has been appointed insolvency practitioner. mr. J.B. Oreel has been appointed supervisory judge. There is 1 public report, dated November 16, 2026. In addition, there is 1 financial report, dated November 16, 2026. Estate assets according to financial report 7: €286,575.99. Key figures according to report 7: unsecured claims €4,922,953.29, creditors 19 en preferential claims €773,908.17. Causes of the bankruptcy according to report 7: completed.
Utrecht recorded 247 bankruptcies in the past twelve months. Of these, 8 came from the municipality of Woerden.
Employees according to report 7 of November 16, 2026: 4.
The company information lists Rondweg 50, 3474KG Zegveld as a business address for Caelus Pharmaceuticals B.V..
On March 5, 2025, the Dutch Insolvency Register published: “Uitspraak faillissement op 04 maart 2025”
Submit a claim
Creditors submit their claim in writing to the insolvency practitioner, stating insolvency number F.13/25/78 and enclosing the supporting documents.
- Deadline for submission
- Not published
Further case information
Status
- Rent and lease
- Mentioned Rent and lease
- Causes of the bankruptcy
- Completed Causes of the bankruptcy
-
De bestuurder heeft verklaard dat de aandeelhouders in maart 2024 een overeenkomst hebben gesloten waarbij zij hun aandelen hebben verkocht aan een investeerder uit de Verenigde Arabische Emiraten, waarbij die investeerder tevens financiering aan de vennootschap zou verstrekken voor de verdere ontwikkeling en vermarkting van het product. Tot overdracht van de aandelen is het echter niet gekomen, o
- Staff
- Mentioned Staff
- Sale of assets
- Mentioned Sale of assets
- Collection of receivables
- Mentioned Collection of receivables
- Security rights
- Mentioned Security rights
- Restart (going-concern sale)
- Mentioned Restart (going-concern sale)
- Bookkeeping obligation
- Mentioned Bookkeeping obligation
- Filing of annual accounts
- Completed Filing of annual accounts
- Director liability
- Mentioned Director liability
- Actio pauliana
- Mentioned Actio pauliana
- Legal proceedings
- Mentioned Legal proceedings
- Lawfulness investigation
- Mentioned Lawfulness investigation
Timeline
Key documents
- View
Financieel verslag 16-11-2026
11-16-2026 9 p. Rechtspraak
- View
Verslag: 16-11-2026
11-16-2026 20 p. Rechtspraak
- View
Uitspraak faillissement op 04 maart 2025
03-05-2025 1 p. Central Insolvency Register
Frequently asked questions about Caelus Pharmaceuticals B.V.
Who has been appointed bankruptcy trustee of Caelus Pharmaceuticals B.V.?
mr. J.F.H.M. Bartels of Labré Advocaten has been appointed bankruptcy trustee by the Rechtbank Amsterdam. The bankruptcy trustee is the point of contact for questions about the bankruptcy.
When was Caelus Pharmaceuticals B.V. declared bankrupt?
On March 4, 2025, Caelus Pharmaceuticals B.V. was declared bankrupt by the Rechtbank Amsterdam. The insolvency number of the case is F.13/25/78.
Where do I submit my claim against Caelus Pharmaceuticals B.V.?
Send your claim in writing to the insolvency practitioner, mr. J.F.H.M. Bartels of Labré Advocaten, with the documents that support it, such as invoices and contracts. Please state insolvency number F.13/25/78.
What does the bankruptcy of Caelus Pharmaceuticals B.V. mean for creditors?
Through the bankruptcy the company loses control of its assets. Control passes to the insolvency practitioner, who sells the assets and distributes the proceeds among the creditors in the statutory ranking. Only at the end is it usually clear whether ordinary creditors receive anything, and how much.
How do I read the reports on the bankruptcy?
The only public report so far appeared on November 16, 2026. It is under Reports in this case.
Company details
- Legal form
- BV
Sources
Not known: founded, kvk registration, trade names